Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1014966.RAPlckDpKoESiM0WeFrfgpdwa7smMGmRRJop8_9KQ7Q-g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1014966.RAPlckDpKoESiM0WeFrfgpdwa7smMGmRRJop8_9KQ7Q-g130_assertion type Assertion NP1014966.RAPlckDpKoESiM0WeFrfgpdwa7smMGmRRJop8_9KQ7Q-g130_head.
- NP1014966.RAPlckDpKoESiM0WeFrfgpdwa7smMGmRRJop8_9KQ7Q-g130_assertion description "[The latter abnormalities are likely to account for the unusual finding that most of SCCHN cell lines are resistant in vitro to HLA class I antigen restricted, tumor antigen (TA)-specific CTL recognition under basal conditions in spite of the expression of TA and HLA class I antigens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1014966.RAPlckDpKoESiM0WeFrfgpdwa7smMGmRRJop8_9KQ7Q-g130_provenance.
- NP1014966.RAPlckDpKoESiM0WeFrfgpdwa7smMGmRRJop8_9KQ7Q-g130_assertion evidence source_evidence_literature NP1014966.RAPlckDpKoESiM0WeFrfgpdwa7smMGmRRJop8_9KQ7Q-g130_provenance.
- NP1014966.RAPlckDpKoESiM0WeFrfgpdwa7smMGmRRJop8_9KQ7Q-g130_assertion SIO_000772 16234579 NP1014966.RAPlckDpKoESiM0WeFrfgpdwa7smMGmRRJop8_9KQ7Q-g130_provenance.
- NP1014966.RAPlckDpKoESiM0WeFrfgpdwa7smMGmRRJop8_9KQ7Q-g130_assertion wasDerivedFrom befree-20150227 NP1014966.RAPlckDpKoESiM0WeFrfgpdwa7smMGmRRJop8_9KQ7Q-g130_provenance.
- NP1014966.RAPlckDpKoESiM0WeFrfgpdwa7smMGmRRJop8_9KQ7Q-g130_assertion wasGeneratedBy ECO_0000203 NP1014966.RAPlckDpKoESiM0WeFrfgpdwa7smMGmRRJop8_9KQ7Q-g130_provenance.